Enterome vs Khartis Therapeutics, Inc.
Enterome vs Khartis Therapeutics, Inc., compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Khartis Therapeutics, Inc. on 53/100.
Where each one leads
Enterome
- our overall score: 60/100 against 53/100
- funding raised: $124M against $50.0M
Khartis Therapeutics, Inc.
- agent readiness: 50/100 against 21/100
At a glance
| Measure | Enterome | Khartis Therapeutics, Inc. |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Developing oral small molecule medicines for immunological and chronic diseases. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Platform |
| Founded | 2012 | 2021 |
| Headquarters | Paris, France | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | Khartis Therapeutics, Inc. |
|---|---|---|
| Employees | 33 | Not published |
| Total funding | $124M | $50.0M |
| Latest round | Later Stage VC | Series B |
| LinkedIn followers | 16,846 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | Khartis Therapeutics, Inc. |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 53/100 |
| Traction | 55/100 | 38/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 34/100 | Not published |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 46/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | Khartis Therapeutics, Inc. |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Analytics 4, Segment | Not detected |
Enterome vs Khartis Therapeutics, Inc.: common questions
Which is better, Enterome or Khartis Therapeutics, Inc.?
On our 0-100 score Enterome rates higher (60/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Enterome and Khartis Therapeutics, Inc. compare on the numbers?
Enterome leads on our overall score (60/100 against 53/100), funding raised ($124M against $50.0M). Khartis Therapeutics, Inc. leads on agent readiness (50/100 against 21/100).
Read the full Enterome review and pricing or the Khartis Therapeutics, Inc. review and pricing. You can also browse other Enterome alternatives we track.